ICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
Follow ICUI
Alert me
ICU Medical, Inc. (ICUI) P/E ratio
As of 6 November 2026, ICU Medical, Inc. (ICUI) trades at a P/E ratio of 71.4×. Over the past ten years it has ranged from 0.0× (December 2025) to 7,927× (January 2026); the current reading is higher than 81% of that period. That is above the Medical Instruments & Supplies industry median of 30.8× and above the Healthcare sector median of 24.5×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 7,134× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 48.7× | (5.71%) |
| FY2020 | 51.7× | 35.62% |
| FY2019 | 38.1× | (76.43%) |
| FY2018 | 162× | 172.15% |
| FY2017 | 59.4× | 51.78% |
| FY2016 | 39.1× | (1.42%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 66.6× | (45.48%) |
| Jun 2026 | 122× | 76.89% |
| Mar 2026 | 69.1× | (99.03%) |
| Dec 2025 | 7,134× | — |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PLSE Pulse Biosciences, Inc compare | n/m |
| MMED MiniMed Group, Inc. compare | n/m |
| NVST Envista Holdings Corporation compare | 6.4× |
| TFX Teleflex Incorporated compare | 18.2× |
| STVN Stevanato Group S.p.A. compare | 23.0× |
| MMSI Merit Medical Systems, Inc. compare | 32.5× |
| ICUI ICU Medical, Inc. | 71.4× |
| ATRC AtriCure, Inc. compare | 192× |
| WRBY Warby Parker Inc. compare | 397× |
| Medical Instruments & Supplies industry median | 30.8× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on ICUI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement